Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajun Wang

Showing results (531-540 of 541) with videos related to

Pageof 55
Sort By:
International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.
Nature Communications|June 18, 2020
Surface regulation enables high stability of single-crystal lithium-ion cathodes at high voltageFang Zhang, Shuaifeng Lou, Shuang Li, et al.
Cell|September 23, 2023
Amyloplast sedimentation repolarizes LAZYs to achieve gravity sensing in plantsJiayue Chen, Renbo Yu, Na Li, et al.
Nature|October 10, 2017
Ion sieving in graphene oxide membranes via cationic control of interlayer spacingLiang Chen, Guosheng Shi, Jie Shen, et al.
Materials Today. Bio|December 8, 2025
Macrophage targeted cellular microparticles synergize anti-tuberculosis therapy combining CircRNA-mediated host immune defense and antibiotic killingYuhe Ma, Fen Yang, Juan Liu, et al.
International Journal of Cancer|October 5, 2019
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responsesHan Zeng, Zheng Liu, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2020
Tumor-infiltrating CD39<sup>+</sup>CD8<sup>+</sup> T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patientsYu Qi, Yu Xia, Zhiyuan Lin, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Intratumoral TIGIT<sup>+</sup> CD8<sup>+</sup> T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancerZhaopei Liu, Quan Zhou, Zewei Wang, et al.
Urologic Oncology|January 1, 2020
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patientsYang Qu, Zhiyuan Lin, Yu Qi, et al.
Pageof 55

Showing results (531-540 of 541) with videos related to

Sort By:
Pageof 55
International Journal of Cancer|August 1, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancerQuan Zhou, Hongyu Zhang, Zewei Wang, et al.
Nature Communications|June 18, 2020
Surface regulation enables high stability of single-crystal lithium-ion cathodes at high voltageFang Zhang, Shuaifeng Lou, Shuang Li, et al.
Cell|September 23, 2023
Amyloplast sedimentation repolarizes LAZYs to achieve gravity sensing in plantsJiayue Chen, Renbo Yu, Na Li, et al.
Nature|October 10, 2017
Ion sieving in graphene oxide membranes via cationic control of interlayer spacingLiang Chen, Guosheng Shi, Jie Shen, et al.
Materials Today. Bio|December 8, 2025
Macrophage targeted cellular microparticles synergize anti-tuberculosis therapy combining CircRNA-mediated host immune defense and antibiotic killingYuhe Ma, Fen Yang, Juan Liu, et al.
International Journal of Cancer|October 5, 2019
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responsesHan Zeng, Zheng Liu, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2019
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic responseYangyang Qi, Yuan Chang, Zewei Wang, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2020
Tumor-infiltrating CD39<sup>+</sup>CD8<sup>+</sup> T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patientsYu Qi, Yu Xia, Zhiyuan Lin, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Intratumoral TIGIT<sup>+</sup> CD8<sup>+</sup> T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancerZhaopei Liu, Quan Zhou, Zewei Wang, et al.
Urologic Oncology|January 1, 2020
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patientsYang Qu, Zhiyuan Lin, Yu Qi, et al.
Pageof 55